SLC6A12 and Alzheimer disease: Consistent with the bioinformatics analysis results, the expression of RHOQ and SLC6A12 was significantly higher in AD mice compared with controls, whereas CARTPT, KLHL35, NRN1, NT5DC3 and PCYOX1L exhibited significant downregulation (Fig. 8B).